Tokyo, June 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062021) titled 'Evaluation of the effects of continuous use of test products on skin condition' on June 23.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled

Primary Sponsor: Institute - Pharma Foods International Co., Ltd.

Condition: Condition - Not applicable Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate the effects of continuous use of test products on skin condition Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Continuous use of the test products

Eligibility: Age-lower limit - 22 years-old

Gender - Male and Female Key inclusion criteria - 1. Men or women 2. Adults (aged 22 to 59) 3. Healthy individuals Key exclusion criteria - 1. Individuals with severe skin conditions, such as dermatitis 2. Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 3. Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD) 4. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, metabolic bone disorders, including osteoporosis and fractures, or any other chronic diseases 5. Individuals who are unable to avoid intentional sun exposure, such as sunbathing, during the study period 6. Individuals with known allergies to medications or test-related substances 7. Individuals who have a present condition or have a medical history of drug or alcohol dependence 8. Individuals who are pregnant, lactating, or planning to become pregnant during this study 9. Individuals who currently or within the past month have a habit of continuous oral intake or topical application of drugs claiming skin improvement benefits, or who are otherwise judged by the principal investigator to be inappropriate for this study 10. Individuals who are using cosmetics with strong moisturizing or anti-wrinkle effects 11. Individuals who are judged as ineligible to participate in this study by the physician Target Size - 20

Recruitment Status: Recruitment status - Enrolling by invitation Date of protocol fixation - 2026 Year 06 Month 10 Day Date of IRB - 2026 Year 06 Month 19 Day Anticipated trial start date - 2026 Year 06 Month 25 Day Last follow-up date - 2026 Year 07 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070972

Disclaimer: Curated by HT Syndication.